Maximus, Inc. (MMS) To Go Ex-Dividend on May 15th

Maximus, Inc. (NYSE:MMS) declared a quarterly dividend on Monday, April 6th. Investors of record on Friday, May 15th will be paid a dividend of 0.33 per share by the health services provider on Monday, June 1st. This represents a c) dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Friday, May 15th.

Maximus has raised its dividend payment by an average of 0.0%annually over the last three years and has increased its dividend annually for the last 2 consecutive years. Maximus has a dividend payout ratio of 19.8% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.32 annual dividend with an expected future payout ratio of 22.9%.

Maximus Stock Performance

MMS stock opened at $65.01 on Wednesday. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $3.55 billion, a price-to-earnings ratio of 9.89 and a beta of 0.63. Maximus has a 12 month low of $60.75 and a 12 month high of $100.00. The firm has a 50 day moving average of $74.42 and a two-hundred day moving average of $83.03.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping the consensus estimate of $1.84 by $0.01. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.61 earnings per share. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts anticipate that Maximus will post 6.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Weiss Ratings downgraded shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.